Apyx Medical Corp Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Apyx Medical Corp (APYX) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of $113.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-13.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2025-03-13
- Apyx Medical Corp effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was $11.00K.
- Apyx Medical Corp effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was -$58.00K, a 192.06% decline year-over-year.
- Apyx Medical Corp effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2022-03-31 was $63.00K.
- Apyx Medical Corp effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2021-03-31 was -$71.00K, a 242.00% decline year-over-year.
- Apyx Medical Corp effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was $113.00K.
- Apyx Medical Corp effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was -$191.00K, a 148.35% decline from fiscal 2022.
- Apyx Medical Corp effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was $395.00K, a 283.50% increase from fiscal 2021.
- Apyx Medical Corp effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2021 was $103.00K.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2024-12-31 | $113.00K 10-K · filed 2025-03-13 | |||
| 2024-06-30 | $30.00K 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | $11.00K 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | -$191.00K 10-K · filed 2025-03-13 | |||
| 2023-09-30 | -$170.00K 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | -$139.00K 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | -$58.00K 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | $395.00K 10-K · filed 2024-03-21 | |||
| 2022-09-30 | $354.00K 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | $163.00K 10-Q · filed 2023-08-11 | |||
| 2022-03-31 | $63.00K 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $103.00K 10-K · filed 2023-03-16 | |||
| 2021-09-30 | -$26.00K 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | -$62.00K 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | -$71.00K 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | -$177.00K 10-K · filed 2022-03-17 | |||
| 2020-09-30 | -$92.00K 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | $9.00K 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | $50.00K 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | $3.00K 10-K · filed 2021-03-31 | |||
| 2019-09-30 | -$18.00K 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | $0.00 10-K · filed 2020-03-31 | |||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-15 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |